Supporting an International Mental Health and Neuromodulation Provider with UK CQC Registration

Neurocare Group is an international specialist healthcare organisation focused on innovative mental health treatments and neuromodulation.

The organisation combines clinical services, neuroscience, medical technology and professional training within a model designed to support personalised mental healthcare.

Its treatment and technology portfolio includes Transcranial Magnetic Stimulation (TMS), Neurofeedback, tDCS, QEEG brain mapping and sleep assessment, with services supporting conditions including depression, ADHD, anxiety, insomnia and obsessive-compulsive disorder.

Neurocare describes its model as bringing together clinical practice, technology, science and digital infrastructure to support personalised treatment pathways. citeturn933389search0turn933389search4

As Neurocare developed its presence within the UK healthcare market, it required an appropriate regulatory framework for the provision of regulated clinical services in England.

QMADS supported Neurocare through the CQC registration process.

Specialist mental health and neuromodulation services present a more complex regulatory position than many conventional healthcare models.

Treatments such as TMS involve the use of specialist medical technology as part of the assessment and treatment of patients with recognised mental health conditions.

The regulatory position therefore needs to consider considerably more than the equipment being used.

It requires consideration of:

• the clinical activities being undertaken;
• the conditions being assessed and treated;
• who is responsible for clinical decisions;
• the qualifications and competency of clinicians;
• patient assessment and suitability;
• treatment protocols;
• clinical risk management;
• consent;
• safeguarding;
• treatment monitoring;
• governance arrangements; and
• the regulated activities applicable to the service.

The challenge is therefore not simply submitting a CQC application.

The provider must be able to demonstrate how an innovative and specialist treatment model fits within the established healthcare regulatory framework.

QMADS supported Neurocare with its CQC registration requirements as the organisation established its UK regulated healthcare operation.

Our role involved helping translate the proposed specialist clinical model into the regulatory structure required for CQC registration.

The fundamental pathway required alignment between:

Patient Need → Clinical Assessment → Specialist Treatment → Clinical Responsibility → Governance → Regulated Activity → CQC Registration

This is particularly important when innovative healthcare technologies are involved.

The fact that a treatment is technologically advanced does not change the underlying regulatory principles. The provider must still demonstrate appropriate clinical accountability, patient safety and governance.

QMADS' involvement focused on supporting the organisation through this regulatory pathway and helping ensure that the proposed model was appropriately presented within the CQC registration framework.

One of the distinguishing features of the Neurocare engagement was the nature of the service itself.

Neurocare operates within an evolving area of mental healthcare where traditional psychological and psychiatric approaches can be combined with technologies such as:

TMS

Neurofeedback

tDCS

EEG and QEEG

Sleep and biometric assessments

The regulatory framework therefore has to accommodate innovation without compromising the fundamental requirements applying to healthcare providers.

This includes establishing clear accountability for patient assessment, treatment decisions, practitioner competency, clinical risk and ongoing monitoring.

Neurocare's wider model has subsequently developed internationally, while its UK presence includes a network of Smart TMS Clinics in locations including Birmingham, Bristol, Manchester, Northampton, Southampton and St Albans. citeturn933389search2

Neurocare Clinics U.K. Ltd successfully achieved CQC registration in England in September 2022, with its registered service specialising in mental health services for adults. citeturn423314search8

Neurocare's UK operating structure has subsequently evolved, and its current UK clinical presence includes Smart TMS Clinics, part of the Neurocare Group.

Smart RTMS Limited is currently registered with CQC to provide:

Treatment of Disease, Disorder or Injury

under its Smart TMS operating model. citeturn423314search1turn423314search6

Neurocare has continued to develop its international clinical and technology platform, combining specialist mental health treatment with neuromodulation technologies, training and clinical research.

QMADS' role was focused on supporting an important stage of the organisation's UK regulatory journey through CQC registration.

Innovative healthcare businesses frequently face a particular regulatory challenge:

Innovation may change how healthcare is delivered, but it does not remove the need for regulatory accountability.

The position can become particularly complex where an organisation:

• introduces innovative medical technology;
• provides specialist mental health treatment;
• treats patients using neuromodulation;
• operates across several clinical locations;
• combines technology and healthcare;
• has an international operating model;
• introduces an established overseas healthcare model into the UK; or
• needs to determine how emerging treatments fit within existing CQC requirements.

These providers require more than administrative registration support.

They need an understanding of both the clinical model and the regulatory environment into which that model is being introduced.

The Neurocare engagement demonstrates QMADS' experience supporting specialist healthcare organisations operating at the intersection of:

MENTAL HEALTH + MEDICAL TECHNOLOGY + CLINICAL GOVERNANCE + CQC REGULATION

QMADS supports specialist healthcare organisations across:

CQC Registration | Mental Health Services | Neuromodulation & Specialist Treatments | Regulatory Scope | Policies & Procedures | Clinical Governance | Registered Manager Support | Interview Preparation | Mock Inspections | Regulatory Consultancy